◼ Archived
Business
Gilead’s IBD drug eliminated symptoms for patients, mid-stage study finds
Gilead's oral drug succeeds in mid-stage ulcerative colitis trials, posting strong remission rates.
3 trends tracked about this subject — the full history, oldest to newest below.
Gilead's oral drug succeeds in mid-stage ulcerative colitis trials, posting strong remission rates.
12 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A genetic link to IBD has been pinpointed after decades of uncertainty—here’s what’s driving the breakthrough